NCT01070238

Brief Summary

The study was conducted

  1. 1.to investigate the superiority of isomaltulose in reduction of postprandial hyperglycemia
  2. 2.to describe the kinetics of glucose absorption after a load of isomaltulose
  3. 3.to demonstrate the safety of a single load of isomaltulose compared to sucrose in type 2 diabetic patients.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 17, 2010

Completed
Last Updated

February 17, 2010

Status Verified

November 1, 2002

First QC Date

February 16, 2010

Last Update Submit

February 16, 2010

Conditions

Keywords

IsomaltuloseSlow Released CarbohydratesPostprandial Glucose MetabolismType 2 diabetes

Outcome Measures

Primary Outcomes (1)

  • Lower postprandial glucose and insulin responses after isomaltulose ingestion than after sucrose

Interventions

IsomaltuloseDIETARY_SUPPLEMENT

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis: type 2 diabetes according to WHO/ADA criteria for more than 1 yr
  • Adults aged 18-75 years old
  • HbA1c \< 8%, fasting blood glucose \< 140 mg/dl
  • For at least 2 months prior to visit 1, subjects must have been on a stable antidiabetic therapy regimen
  • Subjects willing to perform home blood glucose monitoring and to otherwise comply with study protocol requirements

You may not qualify if:

  • Type 1 diabetes mellitus
  • Pregnant or lactating women or women planning to become pregnant
  • Women who become pregnant will be withdrawn from the study
  • Clinically significant heart, liver, lung, or kidney disease
  • Drug or alcohol abuse
  • Concomitant therapy with systemic glucocorticoids or acarbose
  • Subjects unable to adhere to instructions during the qualification phase

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Giessen and Marburg

Giessen, Hesse, 35392, Germany

Location

Related Publications (1)

  • Ang M, Linn T. Comparison of the effects of slowly and rapidly absorbed carbohydrates on postprandial glucose metabolism in type 2 diabetes mellitus patients: a randomized trial. Am J Clin Nutr. 2014 Oct;100(4):1059-68. doi: 10.3945/ajcn.113.076638. Epub 2014 Jul 16.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

isomaltulose

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 16, 2010

First Posted

February 17, 2010

Last Updated

February 17, 2010

Record last verified: 2002-11

Locations